MarketInOut Stock Screener Log In | Sign Up

Hanmi Pharmaceutical Co Ltd

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Hanmi Pharmaceutical Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization4,929,720 mln
Float6.28 mln
Earnings Date02/10/2027

EPS

17,101
Exceptional

P / E

24.27
Premium valuation

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.43
Borderline

1-Year Forecast

654,545
Exceptional upside

Relative Strength

93 / 100
Top performer

Business Description

Founded in 1973 and headquartered in Hwaseong-si, South Korea, Hanmi Pharm is a pharmaceutical company that develops and sells medicines across South Korea, China, Japan, the United States, and other markets. The company concentrates on areas where effective treatments are still lacking, such as weight management, metabolic conditions, cancer, and rare diseases. Among its offerings is Gugutams, a urology product that combines two active compounds to address both prostate enlargement and erectile dysfunction in a single treatment. Hanmi Pharm also works alongside MEDIC Life Sciences to advance cancer research through the identification of biological markers that could improve diagnosis and treatment.

Key Fundamentals

EPS17,101
P/E24.27
ROE17.32
RPS130,517
ROIC12.46
ROA10.08
Interest Cover19.25
EBITDA, mln400,293
EV / EBITDA11.66
EV / EBIT15.52
Revenue, mln1,655,478
EV / Revenue2.82

Quote Details

Last 415,000
Change 26500 (6.82%)
Open 410,000
Volume 247,685
Turnover 102,789,275,648
Average Volume 118,731

Financial Ratios

Pre-Tax Profit Margin17
Leverage Ratio1.66
Current Ratio1.82
Price / Book3.34
Price / Tangible Book3.71
Price / Cash Flow21.11
Price / Free Cash Flow21.66
Debt / Equity0.30
Price / Sales2.84
PEG Ratio1.01

Financial Strength

Altman Z-Score5.56
Piotroski F-Score 7 / 9
Beneish M-Score-2.43
Price to Intrinsic Value1.61
Price to Lynch Fair Value1.68
Price to Graham Number1.89
1-Year Target Price654,545
Shiller PE Ratio49.57

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 14.8% 99 / 100   
1 Month -18.15% 19 / 100   
2 Months 11.41% 85 / 100   
6 Months -15.31% 65 / 100   
1 Year 17.83% 81 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog